国家: 英国
语言: 英文
来源: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sumatriptan succinate
Forest Laboratories UK Ltd
N02CC01
Sumatriptan succinate
50mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04070401
Page 1 of 5 PACKAGE LEAFLET: INFORMATION FOR THE USER IMIGRAN RECOVERY 50MG TABLETS Sumatriptan PATIENT INFORMATION LEAFLET READ THIS LEAFLET CAREFULLY BEFORE TAKING THESE TABLETS. REMEMBER THIS MEDICINE IS FOR YOU. Never give the tablets to someone else, because it may harm them, even if their symptoms seem to be the same as yours. KEEP THIS LEAFLET - you may need to read it again. It contains important information. You must tell your doctor if your pharmacist has confirmed you have migraine and if you take Imigran Recovery. If you have any further questions or there is anything you do not understand, ask your doctor or pharmacist. Throughout this leaflet, Imigran Recovery 50mg Tablets are referred to as Imigran Recovery. IN THIS LEAFLET: 1. What these tablets do 2. Check before you take … 3. How to take the tablets 4. Possible side effects 5. Storing your medicine 6. More about the medicine 7. More about migrane 1. WHAT THESE TABLETS DO Imigran Recovery is used to treat migraine. These tablets contain sumatriptan, which belongs to a group of medicines called triptans (_5-HT, receptor agonists_). Migraine symptoms may be caused by the temporary swelling of blood vessels in the head due to a temporary imbalance in the body’s natural chemicals. The tablets are believed to work on this imbalance and reduce the swelling of these blood vessels. The tablets help to take away the headache and other symptoms of a migraine attack such as feeling sick (nausea) and sensitivity to light and sound. They start to relieve migraine headache about 30 minutes after you take them. 2. CHECK BEFORE YOU TAKE … DON’T TAKE IMIGRAN RECOVERY: unless you suffer from migraines (a doctor or pharmacist needs to confirm this) if you are trying to prevent a migraine attack – only take it when your migraine headache begins until you are sure this is a migraine and not just a headache if you are under 18 or over 65 if you have had an allergic reaction to sumatriptan, or any of the other ingredients in the tablets, o 阅读完整的文件
OBJECT 1 IMIGRAN RECOVERY Summary of Product Characteristics Updated 12-Jun-2014 | Forest Laboratories UK Limited (a subsidiary of Actavis PLC) 1. Name of the medicinal product Imigran Recovery, 50 mg, film-coated tablets. 2. Qualitative and quantitative composition 50 mg sumatriptan base (as the succinate salt). For excipients, see Section 6.1. 3. Pharmaceutical form Film-coated tablet. Pink, film-coated, triangular shaped, biconvex tablets debossed with 'GS 1YM' on one face and '50' on the other. 4. Clinical particulars 4.1 Therapeutic indications Imigran Recovery is indicated for the acute relief of migraine attacks, with or without aura. Imigran Recovery should only be used where there is a clear diagnosis of migraine. 4.2 Posology and method of administration ADULTS (18-65 YEARS OF AGE) The recommended dose is a single 50 mg tablet that should be swallowed whole with water. It is advisable that Imigran Recovery be taken as soon as possible after the onset of a migraine headache although it is effective at whatever stage of the headache it is taken. If there is a response to the first tablet but the symptoms recur, a second tablet may be taken. However, this must be at least 2 hours after the first tablet. No more than two 50 mg tablets (total dose 100 mg) may be taken in any 24 hour period or to treat the same attack. If there is no response to the first tablet, a second tablet should not be taken for the same attack. CHILDREN AND ADOLESCENTS (UNDER 18 YEARS OF AGE) Not to be used in children or adolescents under 18 years of age. The safety and effectiveness of Imigran Recovery in children have not been established. ELDERLY (OVER 65 YEARS OF AGE) Not to be used in those over 65 years of age. Experience of the use of Imigran Recovery in patients over 65 years is limited. 4.3 Contraindications Imigran Recovery must not be used prophylactically. Hypersensitivity to any component of the preparation or to sulphonamides. Previous myocardial infarction, or those who have ischaemic heart disease, coronary vasospasm 阅读完整的文件